{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:04:43Z","timestamp":1753891483860,"version":"3.41.2"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Neutralizing antibodies (nAbs) are pivotal in developing fast, broadly protective therapeutics against novel pandemic viruses. Despite their well-known direct neutralization capacity, their effector mechanisms via Fc receptors remain poorly understood. Identifying the types of effector cells engaged in antibody-mediated effector functions is essential for regulating their activities. Using the lymphocytic choriomeningitis virus (LCMV), we show that nAbs obtained from immune sera or monoclonal LCMV-specific nAbs show dependency on Fc receptors. We demonstrate that therapy with nAbs is highly protective in the presence of patrolling monocytes. These monocytes bind nAbs primarily via Fc\u03b3RIV, targeting virus-infected cells, and thereby limiting virus propagation. Depleting patrolling monocytes or blocking Fc\u03b3RIV resulted in a substantial loss of virus control by nAbs, indicating the pivotal role of patrolling monocytes in the antiviral activity of these antibodies. In conclusion, our findings highlight that, alongside direct neutralization, nAbs primarily exert their effects through the involvement of patrolling monocytes.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1600056","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T05:26:21Z","timestamp":1748496381000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Patrolling monocytes mediate virus neutralizing IgG effector functions: beyond neutralization capacity"],"prefix":"10.3389","volume":"16","author":[{"given":"Abdelrahman","family":"Elwy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Swati","family":"Dhiman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossam","family":"Abdelrahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Specht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theresa Charlotte","family":"Christ","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Falkenstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harpreet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Holnsteiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith","family":"Lang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Mack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Falk","family":"Nimmerjahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wiebke","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl Sebastian","family":"Lang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2012.03.021","article-title":"Isotype and glycoform selection for antibody therapeutics","volume":"526","author":"Jefferis","year":"2012","journal-title":"Arch Biochem Biophys"},{"key":"B2","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/nri2206","article-title":"Fc\u03b3 receptors as regulators of immune responses","volume":"8","author":"Nimmerjahn","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22168947","article-title":"The role of fc receptors on the effectiveness of therapeutic monoclonal antibodies","volume":"22","author":"Gogesch","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00548","article-title":"Fc-mediated antibody effector functions during respiratory syncytial virus infection and disease","volume":"10","author":"van Erp","year":"2019","journal-title":"Front Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-022-00501-8","article-title":"Avidity in antibody effector functions and biotherapeutic drug design","volume":"21","author":"Oostindie","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"B6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.immuni.2005.11.010","article-title":"Fc\u03b3 receptors: old friends and new family members","volume":"24","author":"Nimmerjahn","year":"2006","journal-title":"Immunity"},{"key":"B7","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.1016\/j.celrep.2019.10.111","article-title":"The immunological organ environment dictates the molecular and cellular pathways of cytotoxic antibody activity","volume":"29","author":"Gordan","year":"2019","journal-title":"Cell Rep"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1084\/jem.191.8.1293","article-title":"Markedly different pathogenicity of four immunoglobulin G isotype-switch variants of an antierythrocyte autoantibody is based on their capacity to interact in vivo with the low-affinity Fc\u03b3 receptor III","volume":"191","author":"Fossati-Jimack","year":"2000","journal-title":"J Exp Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.12.8745","article-title":"Fc\u03b3RIII and Fc\u03b3RIV are indispensable for acute glomerular inflammation induced by switch variant monoclonal antibodies","volume":"181","author":"Giorgini","year":"2008","journal-title":"J Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20052283","article-title":"Antibody isotype-specific engagement of Fc\u03b3 receptors regulates B lymphocyte depletion during CD20 immunotherapy","volume":"203","author":"Hamaguchi","year":"2006","journal-title":"J Exp Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1126\/science.1118948","article-title":"Divergent immunoglobulin g subclass activity through selective Fc receptor binding","volume":"310","author":"Nimmerjahn","year":"2005","journal-title":"Science"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.04.016","article-title":"Differential fc-receptor engagement drives an anti-tumor vaccinal effect","volume":"161","author":"DiLillo","year":"2015","journal-title":"Cell"},{"key":"B13","doi-asserted-by":"publisher","first-page":"4873","DOI":"10.1016\/j.cell.2022.11.012","article-title":"Antibody effector functions are associated with protection from respiratory syncytial virus","volume":"185","author":"Bartsch","year":"2022","journal-title":"Cell"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00440","article-title":"Extra-neutralizing fcR-mediated antibody functions for a universal influenza vaccine","volume":"10","author":"Boudreau","year":"2019","journal-title":"Front Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/13.1.108","article-title":"Role of antibody-dependent cellular cytotoxicity in defense against herpes simplex virus infections","volume":"13","author":"Steve","year":"1991","journal-title":"Rev Infect Dis"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2008236117","article-title":"Fc-mediated effector function contributes to the in vivo antiviral effect of an HIV neutralizing antibody","volume":"117","author":"Asokan","year":"2020","journal-title":"Proc Natl Acad Sci"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.12.7381","article-title":"Fc receptor-mediated phagocytosis makes a significant contribution to clearance of influenza virus infections","volume":"166","author":"Huber","year":"2001","journal-title":"J Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00332","article-title":"Antibody-dependent cellular phagocytosis in antiviral immune responses","volume":"10","author":"Tay","year":"2019","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"7165","DOI":"10.1038\/s41598-020-64158-2","article-title":"Ly6cLo non-classical monocytes promote resolution of rhesus rotavirus-mediated perinatal hepatic inflammation","volume":"10","author":"Alkhani","year":"2020","journal-title":"Sci Rep"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2011.11.009","article-title":"Monocyte subsets responsible for immunoglobulin G-dependent effector functions in vivo","volume":"35","author":"Biburger","year":"2011","journal-title":"Immunity"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.08.009","article-title":"Triggering of NOD2 receptor converts inflammatory ly6C(high) into ly6C(low) monocytes with patrolling properties","volume":"20","author":"Lessard","year":"2017","journal-title":"Cell Rep"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20051557","article-title":"Nonneutralizing antibodies binding to the surface glycoprotein of lymphocytic choriomeningitis virus reduce early virus spread","volume":"203","author":"Hangartner","year":"2006","journal-title":"J Exp Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201343566","article-title":"Non-neutralizing antibodies protect from chronic LCMV infection independently of activating Fc\u03b3R or complement","volume":"43","author":"Richter","year":"2013","journal-title":"Eur J Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201343565","article-title":"Nucleoprotein-specific nonneutralizing antibodies speed up LCMV elimination independently of complement and Fc\u03b3R","volume":"43","author":"Straub","year":"2013","journal-title":"Eur J Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202049068","article-title":"Non-neutralizing antibodies protect against chronic LCMV infection by promoting infection of inflammatory monocytes in mice","volume":"51","author":"Stoycheva","year":"2021","journal-title":"Eur J Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110303","article-title":"Antibody bivalency improves antiviral efficacy by inhibiting virion release independently of Fc gamma receptors","volume":"38","author":"Sahin","year":"2022","journal-title":"Cell Rep"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.celrep.2019.12.023","article-title":"Chronic viral infection promotes efficient germinal center B cell responses","volume":"30","author":"Fallet","year":"2020","journal-title":"Cell Rep"},{"key":"B28","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.celrep.2019.12.088","article-title":"Quantitative and qualitative analysis of humoral immunity reveals continued and personalized evolution in chronic viral infection","volume":"30","author":"Kr\u00e4utler","year":"2020","journal-title":"Cell Rep"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00955-07","article-title":"Early antibodies specific for the neutralizing epitope on the receptor binding subunit of the lymphocytic choriomeningitis virus glycoprotein fail to neutralize the virus","volume":"81","author":"Eschli","year":"2007","journal-title":"J Virol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-023-00858-w","article-title":"Antiviral neutralizing antibodies: from in vitro to in vivo activity","volume":"23","author":"Burton","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1014515107","article-title":"Fc\u03b3RIV deletion reveals its central role for IgG2a and IgG2b activity in vivo","volume":"107","author":"Nimmerjahn","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.7.4697","article-title":"Expression and characterization of the chemokine receptors CCR2 and CCR5 in mice","volume":"166","author":"Mack","year":"2001","journal-title":"J Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/nn2015","article-title":"Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions","volume":"10","author":"Mildner","year":"2007","journal-title":"Nat Neurosci"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2015.1011450","article-title":"Macrophages are critical effectors of antibody therapies for cancer","volume":"7","author":"Weiskopf","year":"2015","journal-title":"MAbs"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0191690","article-title":"Splenic macrophages are required for protective innate immunity against West Nile virus","volume":"13","author":"Bryan","year":"2018","journal-title":"PloS One"},{"key":"B36","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/hep.23640","article-title":"Tissue macrophages suppress viral replication and prevent severe immunopathology in an interferon-I-dependent manner in mice","volume":"52","author":"Lang","year":"2010","journal-title":"Hepatology"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01624-16","article-title":"Broadly neutralizing hemagglutinin stalk-specific antibodies induce potent phagocytosis of immune complexes by neutrophils in an fc-dependent manner","volume":"7","author":"Mullarkey","year":"2016","journal-title":"mBio"},{"key":"B38","doi-asserted-by":"publisher","first-page":"105","DOI":"10.21037\/atm.2019.01.42","article-title":"NK-mediated antibody-dependent cell-mediated cytotoxicity in solid tumors: biological evidence and clinical perspectives","volume":"7","author":"Lo Nigro","year":"2019","journal-title":"Ann Transl Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"5170","DOI":"10.1038\/s41467-023-40699-8","article-title":"Antibody-mediated NK cell activation as a correlate of immunity against influenza infection","volume":"14","author":"Boudreau","year":"2023","journal-title":"Nat Commun"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.Ccr-07-0865","article-title":"The activation of natural killer cell effector functions by cetuximab-coated, epidermal growth factor receptor\u2013positive tumor cells is enhanced by cytokines","volume":"13","author":"Roda","year":"2007","journal-title":"Clin Cancer Res"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jim.2011.03.005","article-title":"Mouse blood monocytes: Standardizing their identification and analysis using CD115","volume":"390","author":"Breslin","year":"2013","journal-title":"J Immunol Methods"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20062648","article-title":"Notch\u2013RBP-J signaling controls the homeostasis of CD8\u2013 dendritic cells in the spleen","volume":"204","author":"Caton","year":"2007","journal-title":"J Exp Med"},{"key":"B43","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/s0065-2776(01)77018-6","article-title":"The antiviral activity of antibodies in vitro and in vivo","volume":"77","author":"Parren","year":"2001","journal-title":"Adv Immunol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/978-3-662-05783-4_4","article-title":"Structural studies on viral escape from antibody neutralization","volume":"260","author":"Bizebard","year":"2001","journal-title":"Curr Top Microbiol Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1600056\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T05:26:21Z","timestamp":1748496381000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1600056\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,29]]},"references-count":44,"alternative-id":["10.3389\/fimmu.2025.1600056"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1600056","relation":{},"ISSN":["1664-3224"],"issn-type":[{"type":"electronic","value":"1664-3224"}],"subject":[],"published":{"date-parts":[[2025,5,29]]},"article-number":"1600056"}}